MENU
+Compare
AKBA
Stock ticker: NASDAQ
AS OF
Jan 22, 04:59 PM (EDT)
Price
$2.38
Change
+$0.01 (+0.42%)
Capitalization
521.45M

AKBA stock forecast, quote, news & analysis

Industry: @Biotechnology
AKBA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
A.I.Advisor
published price charts
Ad is loading...
A.I.Advisor
a Summary for AKBA with price predictions
Jan 08, 2025

AKBA's Stochastic Oscillator dives oversold zone

The Stochastic Oscillator for AKBA moved into oversold territory on January 08, 2025. Be on the watch for the price uptrend or consolidation in the future. At that time, consider buying the stock or exploring call options.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where AKBA advanced for three days, in of 270 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on January 08, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on AKBA as a result. In of 81 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

AKBA moved below its 50-day moving average on January 06, 2025 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for AKBA crossed bearishly below the 50-day moving average on January 08, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 14 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where AKBA declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

A.I.Advisor
published Highlights

Market Cap

The average market capitalization across the group is 521.45M. The market cap for tickers in the group ranges from 521.45M to 521.45M. AKBA holds the highest valuation in this group at 521.45M. The lowest valued company is AKBA at 521.45M.

High and low price notable news

The average weekly price growth across all stocks in the group was 23%. For the same group, the average monthly price growth was 29%, and the average quarterly price growth was 66%. AKBA experienced the highest price growth at 23%, while AKBA experienced the biggest fall at 23%.

Volume

The average weekly volume growth across all stocks in the group was 79%. For the same stocks of the group, the average monthly volume growth was 126% and the average quarterly volume growth was 239%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 82
P/E Growth Rating: 100
Price Growth Rating: 36
SMR Rating: 100
Profit Risk Rating: 100
Seasonality Score: 50 (-100 ... +100)
View a ticker or compare two or three
AKBA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published General Information

General Information

a developer of drugs for the treatment of anemia and vascular diseases

Industry

Profile
Fundamentals
Details
Industry
Biotechnology
Address
245 First Street
Phone
+1 617 871-2098
Employees
167
Web
https://www.akebia.com